Ellevest Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.01M Buy
3,274
+57
+2% +$57.8K 0.42% 35
2025
Q4
$3.46M Sell
3,217
-52
-2% -$49.7K 0.48% 33
2025
Q3
$2.49M Sell
3,269
-252
-7% -$188K 0.36% 36
2025
Q2
$2.74M Sell
3,521
-60
-2% -$46.6K 0.44% 33
2025
Q1
$2.96M Buy
3,581
+2
+0.1% +$1.66K 0.2% 41
2024
Q4
$2.76M Sell
3,579
-221
-6% -$183K 0.16% 46
2024
Q3
$3.37M Buy
3,800
+38
+1% +$34.2K 0.19% 41
2024
Q2
$3.41M Buy
3,762
+261
+7% +$209K 0.2% 40
2024
Q1
$2.72M Buy
3,501
+87
+3% +$61.9K 0.17% 47
2023
Q4
$1.99M Buy
3,414
+591
+21% +$345K 0.14% 50
2023
Q3
$1.52M Buy
2,823
+80
+3% +$41.2K 0.12% 53
2023
Q2
$1.29M Buy
2,743
+170
+7% +$71.3K 0.1% 56
2023
Q1
$884K Buy
2,573
+78
+3% +$26.3K 0.07% 68
2022
Q4
$913K Buy
2,495
+215
+9% +$76.2K 0.08% 69
2022
Q3
$737K Buy
2,280
+217
+11% +$68.8K 0.07% 64
2022
Q2
$669K Buy
2,063
+1,487
+258% +$446K 0.06% 76
2022
Q1
$165K Sell
576
-1,173
-67% -$302K 0.01% 340
2021
Q4
$483K Buy
1,749
+1,213
+226% +$307K 0.04% 111
2021
Q3
$124K Buy
536
+43
+9% +$10.6K 0.01% 354
2021
Q2
$113K Sell
493
-1,194
-71% -$240K 0.01% 354
2021
Q1
$315K Buy
1,687
+125
+8% +$24.5K 0.04% 123
2020
Q4
$264K Buy
1,562
+403
+35% +$60.2K 0.04% 125
2020
Q3
$172K Buy
1,159
+54
+5% +$8.36K 0.03% 146
2020
Q2
$181K Buy
1,105
+418
+61% +$64.2K 0.04% 125
2020
Q1
$95K Buy
687
+211
+44% +$29K 0.03% 147
2019
Q4
$63K Buy
476
+261
+121% +$30.3K 0.02% 148
2019
Q3
$24K Buy
215
+20
+10% +$2.23K 0.01% 170
2019
Q2
$22K Buy
195
+106
+119% +$12.5K 0.01% 191
2019
Q1
$12K Hold
89
0.01% 179
2018
Q4
$10K Buy
+89
New +$9.94K 0.01% 380

Other funds holding LLY

Ellevest Inc's LLY Position: Q1 2026 in Review

Ellevest Inc increased its Eli Lilly (LLY) stake by 1.8% in Q1 2026, buying an estimated $57.8K and bringing the position to 3,274 shares worth $3.01M. The position accounts for 0.42% of the portfolio, ranked #35.

Ellevest Inc first reported a position in LLY in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.46M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Ellevest Inc held 3,274 shares of Eli Lilly worth $3.01M as of Q1 2026.
  • Ellevest Inc bought 57 Eli Lilly shares in Q1 2026, an estimated $57.8K.
  • Eli Lilly made up 0.42% of Ellevest Inc's portfolio in Q1 2026, its #35 holding.
  • Ellevest Inc first reported a position in Eli Lilly in Q4 2018 and has held it in 30 quarters since.
  • Ellevest Inc's Eli Lilly position peaked at $3.46M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ellevest Inc's 13F filing for Q1 2026, filed 11 May 2026.